![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00403-024-02967-5/MediaObjects/403_2024_2967_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00403-024-02967-5/MediaObjects/403_2024_2967_Fig2_HTML.png)
Data availability
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to the privacy or ethical restrictions.
References
Mrowietz U, de Jong EM, Kragballe K et al (2014) A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol 28(4):438–453. https://doi.org/10.1111/jdv.12118
Armstrong AW, Patel M, Li C et al (2023) Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States. J Dermatolog Treat 34(1):2200870. https://doi.org/10.1080/09546634.2023.2200870
Özkur E, Kıvanç Altunay İ, Oğuz Topal İ et al (2021) Switching Biologics in the treatment of Psoriasis: a Multicenter experience. Dermatology 237(1):22–30. https://doi.org/10.1159/000504839
Pezzolo E, Cazzaniga S, Di Leo S, Naldi L (2022) Efficacy and safety of Dimethyl fumarate in comparison with conventional therapy for psoriasis: an Italian real-world clinical experience. J Eur Acad Dermatol Venereol 36(7):e534–e537. https://doi.org/10.1111/jdv.17997
Edmonds J (1967) Optimum branchings. Journal of Research of the National Bureau of standards. Sect B 71B:233–240
Funding
The study received an unconditioned grant from Almirall.
Author information
Authors and Affiliations
Contributions
Conceptualization: LN; Data Curation; EP, SDL, SC; Formal analysis: SC; Funding acquisition: LN, SC; Investigation: FC; Methodology: SC; Project administration: EP; Resources: LN, EP, SC; Software: SC; Supervision: LN, EP, SC; Validation: EP, LN, SC; Visualization: SC, EP, FC; Writing-Original Draft Preparation: EP, LN; Writing, Review and Editing: EP, LN, SC.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Patient consent
No recognizable patient photographs or other identifiable material was included.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pezzolo, E., Cazzaniga, S., Cassalia, F. et al. Trajectories of switching to optimise efficacy and minimising risks in patients with moderate-to-severe plaque psoriasis: results from the PsoReal registry. Arch Dermatol Res 316, 263 (2024). https://doi.org/10.1007/s00403-024-02967-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00403-024-02967-5